Nasdaq

Biosense Webster Presents Late-Breaking Data from inspIRE and admIRE Clinical Trials at AF Symposium

IRVINE, Calif., Feb. 2, 2024 /PRNewswire/ -- Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi, announced 12-month results from the company ...
Business Insider

Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy

First and only AFib ablation products to receive approval for use in a workflow without fluoroscopy from the U.S. Food and Drug Administration Enables workflows with zero fluoroscopy during catheter ...
Orange County Business Journal

Biosense Webster Aims to Reduce Radiation Exposure

Webster has developed the Carto 3 mapping and navigation system that provides 3D imaging Irvine-based Biosense Webster, a unit of Johnson & Johnson, said it’s developed a way to help patients and ...
FierceBiotech

Biosense Webster Receives FDA Clearances for the CARTOXPRESS™ Software Module and LASSO® NAV Catheter for its CARTO®

State-of-the-Art Software and new sensor-enabled catheter provides Electrophysiologists with an unparalleled level of speed and visualization in their 3D Mapping and Ablation procedures. FAM is a ...
FierceBiotech

Electrophysiology cardiac catheter from J&J's Biosense Webster in ongoing recall

The FDA has issued a Class 2 recall notice for an electrophysiology cardiac catheter from Biosense Webster, which is a Johnson & Johnson ($JNJ) company, due to ...
Nasdaq

New Biosense Webster QDOT MICRO™ Catheter Data Demonstrate Very High-Power, Short-Duration Ablations Improved Quality of Life and Reduced Healthcare Utilization for AFib Patients

IRVINE, Calif., Nov. 2, 2023 /PRNewswire/ -- Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i announced new findings from the Q-FFICIENCY ...
PharmiWeb

Biosense Webster Launches the OPTRELL™ Mapping Catheter with TRUEref™ Technology for Mapping of Complex Cardiac Arrhythmias

Industry’s highest density fixed array mapping catheter, covering the largest area in a fixed matrix format, can help physicians effectively map in a shorter procedure time IRVINE, CA – July 24, 2023 ...
TCTMD

Biosense Webster Announces Initial Results From First In-Human Study Of Novel High Power-Short Duration Ablation Catheter For Atrial Fibrillation

SAN FRANCISCO – Johnson & Johnson Medical Devices Companies* today announced that Biosense Webster, Inc.’s QDOT MICRO, a novel catheter that facilitates high power-short duration radiofrequency (RF) ...
FiercePharma

Biosense Webster Enrolls First Patient in Groundbreaking SMART-AF Trial

Completes First Atrial Fibrillation Ablation Case in the United States Using The THERMOCOOL ® SMARTTOUCH ™ Contact Force Sensing Catheter & Software Module DIAMOND BAR, Calif.--(BUSINESS WIRE)-- ...
Business Wire

Biosense Webster, Inc. Launches Outcomes-Based, Risk-Sharing Program to Reinforce Significant Patient Benefits Demonstrated by Company’s Leading Contact Force Therapy

DIAMOND BAR, Calif.--(BUSINESS WIRE)--Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced the launch of the BIOSENSE WEBSTER ADVANTAGE SM ...
Business Wire

Biosense Webster Receives FDA Approval for First Catheter Ablation Therapy in the U.S. to Feature Direct Contact Force Technology for Treatment of Atrial Fibrillation

DIAMOND BAR, Calif.--(BUSINESS WIRE)--Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced today that it has received approval from the United ...